Scarica l'app Stockscreener
26.44
1.30%
0.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Pfizer Reshapes Portfolio With New Partnerships Oncology Push And Pricing Shifts - Yahoo Finance
This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? - The Motley Fool
‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology - Yahoo Finance
Pfizer: Buyer Beware, The Risk Outweighs The Reward (NYSE:PFE) - Seeking Alpha
Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings? - Finviz
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know - Yahoo Finance
Pfizer Inc (NYSE:PFE) Emerges as a High-Quality Technical Breakout Candidate - Chartmill
Pfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19 - Yahoo Finance
PFIZER Stock Holds Near $25.86 as Forecast Targets $36.16 Upside - Analytics Insight
Ahead of Pfizer (PFE) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Price Over Earnings Overview: Pfizer - Benzinga
Pfizer: A High-Yield Pharma At A Turning Point (NYSE:PFE) - Seeking Alpha
Can't compromise nation's sovereignty: Supreme Court to settle law on Letters Rogatory in Pfizer-Softgel case - Bar and Bench
'Will US Authorities Cooperate If Indians Seek Information?' : Supreme Court Asks Pfizer On Plea To... - Live Law
Pfizer Inks $530M Deal for Novavax Matrix-M Adjuvant Technology to Boost Vaccine Pipeline - Finviz
Is There Now An Opportunity In Pfizer (PFE) After Recent Pandemic Demand Reset? - simplywall.st
Pfizer's Revenue Rebound Potential is Significant - Intellectia AI
TrumpRx Launch: Pfizer (PFE) and Other Pharma Giants Join New Pl - GuruFocus
Wolfe Research Adjusts Price Target on Pfizer to $25 From $24, Maintains Underperform Rating - marketscreener.com
Has Novavax cracked the code for survival in the vaccine arena? - Pharma Voice
Pfizer Reshapes Portfolio As ViiV Exit Meets White House Pricing Deal - Yahoo Finance
Biosimilars Market Huge Growth in Future Scope 2026-2033 | Amgen Inc., Pfizer Inc., Samsung Bioepis Co., Ltd. - openPR.com
CMS Names Pfizer, Eli Lilly, and AbbVie Drugs for Third Medicare Price Talks - TipRanks
Pfizer Reshapes Pipeline With Novavax Deal And ViiV Exit - simplywall.st
Pfizer (PFE) Among Firms Facing Medicare Drug Price Negotiations - GuruFocus
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
US names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks - marketscreener.com
US names HIV, arthritis drugs for next Medicare price talks - Reuters
What are Wall Street analysts' target price for Pfizer stock? - MSN
US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks - Yahoo! Finance Canada
Pfizer Enters into Agreement with Walgreens to Help Eligible U.S. Adults Navigate Their Healthcare Journey - Pfizer
The Analyst Verdict: Pfizer In The Eyes Of 7 Experts - Benzinga
Pfizer (PFE) Analyst Rating Update: Cantor Fitzgerald Raises Pri - GuruFocus
Why Is Pfizer Stock Rising Tuesday? - Benzinga
Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's Drug - Benzinga
Earnings Preview: Pfizer (PFE) Q4 Earnings Expected to Decline - Finviz
CMA Seeks To Appeal Re-Do Of £70M Pfizer, Flynn Drug Fines - Law360
118,500 Shares in Pfizer Inc. $PFE Acquired by Y Intercept Hong Kong Ltd - MarketBeat
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively - Yahoo Finance
Macrolide Antibiotics Market to Witness Stunning Growth - openPR.com
Pfizer vs. Merck Stock And JNJ - Forbes
With 66% Ownership of the Shares, Pfizer Inc. (NYSE:PFE) Is Heavily Dominated by Institutional Owners - 富途牛牛
Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance (NYSE:PFE) - Seeking Alpha
Pfizer’s CEO on leading after a moonshot—and making deals with Trump - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sundrug Co (OtherSDGCF) - The Globe and Mail
What Are Wall Street Analysts' Target Price for Pfizer Stock? - Barchart.com
Pfizer CEO Albert Bourla stared down the COVID-19 pandemic. Now he has his eyes set on cancer - Fortune
Pfizer (PFE) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Pfizer Inc. - Britannica
Pfizer Recasts Infectious Disease Focus With ViiV Exit And Matrix M Access - simplywall.st
Pfizer and BioNTech Move Closer to a Single-Shot Flu–COVID Vaccine: What Investors Should Watch - TipRanks
Recent Report Shows That Rep. French Hill Sold Up to $365K Worth of Pfizer Stock - Benzinga
Pfizer Stock Forecast 2026–2030 | Future Outlook - Capital.com
Parthenon LLC Has $1.27 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Corticosteroids Market Report 2026 - GlobeNewswire Inc.
Callahan Advisors LLC Acquires 43,454 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Avantax Planning Partners Inc. - MarketBeat
Pfizer to exit ViiV Healthcare as GSK and Shionogi reshape ownership - MSN
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership - Yahoo Finance
Quilter Plc Cuts Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Sector Gamma AS Increases Stake in Pfizer Inc. $PFE - MarketBeat
UniSuper Management Pty Ltd Increases Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
1.72%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):